The lunula is the pale half-moon at the base of a fingernail. When it turns blue or slate gray while the rest of the nail bed stays normal, the list of explanations gets very short, and one entry on it is a metal that never leaves the body.
An 88-year-old man presented to a dermatology team at the University of Oklahoma with exactly that pattern, unchanged for 50 years. The discoloration covered the proximal fingernails of both hands and stopped at the edge of the lunulae. There was no nail plate damage, no toenail involvement, and no other skin or mucous membrane findings. On questioning, he disclosed a lifetime history of colloidal silver use, applied to the skin as an antiseptic and used in the mouth for canker sores.
The diagnosis, published in Cutis, was argyria-induced azure lunulae. His nails looked the same months later, as the team expected.
Why The Nails Can Show It First
Argyria is an acquired condition caused by excessive exposure to silver, which is absorbed through the gut and deposits as granules in tissue. Silver favors stromal tissue and basement membranes while sparing the outer layer of skin, which is why the result is a progressive, permanent blue-to-slate-gray discoloration of sun-exposed skin, mucous membranes, and nail beds.
The nail is where the process can surface before the face and hands do. The Oklahoma authors note that nail involvement may be an early presentation of generalized argyria or may occur in isolation, as it did here. A 2022 case report in Cureus described argyria confined entirely to the nails following colloidal silver ingestion, detected on a routine examination before any wider pigment changes appeared. Its authors made the same argument: with supplement use widespread, clinicians should learn to spot the subtle version.
The Short List of Things That Turn Lunulae Blue
Blue-gray nail beds have a broad differential that includes cyanosis from heart or lung disease, drug-induced pigmentation, Wilson disease, gold deposition, hereditary acrolabial telangiectasia, and pseudomonal nail infection.
Only a few of those spare the distal nail bed and confine the color to the crescent, the pattern called azure lunulae. Argyria is one. Wilson disease is another, though it usually brings liver, eye, and neurological findings and often a family history. Drug-induced pigmentation from phenolphthalein-containing laxatives is a third, and largely historical, since the FDA banned phenolphthalein from over-the-counter laxatives in 1999 over cancer concerns.
One detail helps separate the two main contenders: toenails are typically spared in argyria, while toenail involvement in Wilson disease is variable. Medications more commonly linked to bluish nail beds include antimalarials, amiodarone, minocycline, clofazimine, phenothiazines, and several chemotherapy drugs. This patient was taking none of them.
What Regulators Have Said, Repeatedly
The FDA settled the question of oral silver more than a quarter-century ago. Under a 1999 final rule, now codified at 21 CFR 310.548, the agency found that there is insufficient data to establish that colloidal silver ingredients or silver salts are generally recognized as safe and effective for treating or preventing any disease. Any such over-the-counter product promoted for a disease is treated as an unapproved new drug and, absent approval, as misbranded. After September 16, 1999, non-compliant products became subject to regulatory action.
Colloidal silver is nonetheless still widely sold as a dietary supplement, a category with different rules. The National Center for Complementary and Integrative Health notes that the FDA has warned that colloidal silver is not safe or effective for treating any disease or condition, that argyria is its most common serious side effect, and that it can impair absorption of some drugs, including certain antibiotics and thyroxine, with some evidence of kidney, liver, and nervous system problems.
Enforcement continues. In a warning letter issued in 2025, the FDA told a Florida company that two colloidal silver douche products it sold online were unapproved new drugs that had been introduced into interstate commerce in violation of federal law.
Treatment Is Limited, So Recognition Matters
There is no reliable way to undo the pigment. Cutaneous argyria has, in some reports, responded to a 1064-nm Q-switched Nd:YAG laser, but the Cutis authors note that no treatments have been reported for nail-bed involvement.
The upside of an early nail sign is that it can stop further accumulation. Discontinuing the silver source prevents further deposition, even though it does not remove what is already there. In the Oklahoma case, with no systemic symptoms and no cosmetic concern from the patient, that was the only step taken.
The systemic picture is less alarming than the color suggests. There is limited research supporting adverse systemic effects when argyria is confined to the nail beds, and most generalized cases are not associated with systemic complications. Reported toxicities such as night blindness, kidney or liver effects, lung fibrosis, and neuropsychiatric events come from isolated case reports without established causal relationships.
Anyone who notices a persistent blue-gray change in the nails, skin, or gums should see a clinician rather than self-diagnose, and should mention every supplement and over-the-counter product they use. As this case shows, the exposure is often the thing the patient never thinks to volunteer.
Key Questions Answered
What is argyria? A condition in which silver absorbed over time deposits as granules in tissue, producing a blue-gray discoloration of skin, nails, and mucous membranes that is usually permanent.
What are azure lunulae? Blue-gray discoloration confined to the pale crescents at the base of the fingernails, with the rest of the nail bed spared. Argyria, Wilson disease and certain drug exposures can produce this pattern.
Can the color be reversed? No reliable treatment exists. Laser treatment has produced some improvement in skin argyria, and no treatments have been reported for nail bed involvement.
Is colloidal silver approved for any medical use? No. Under a 1999 rule, over-the-counter drug products containing colloidal silver or silver salts that are promoted for treating or preventing disease are treated as unapproved new drugs and as misbranded.
Does nail-only argyria cause other health problems? There is limited research supporting adverse systemic effects when argyria is confined to the nail beds, and most generalized cases are not associated with systemic complications.
What should someone do if they notice blue-gray nails? See a clinician for evaluation and disclose all supplements and over-the-counter products used, since the differential includes cardiopulmonary, metabolic, and medication-related causes.
